What Is an A+H Issuer?
An A+H issuer is a joint stock company whose A shares (RMB-denominated) are listed on a mainland exchange (the SSE or the SZSE) while its H shares (HKD-denominated) are listed on The Stock Exchange of Hong Kong. A shares and H shares are two classes of domestically and overseas listed shares of the same issuer, with identical rights and the same underlying fundamentals, trading separately on two markets and forming separate prices.
1. The structure defined
Dual listing: An A+H company combines A shares listed on the mainland with H shares listed in Hong Kong. A shares face mainland investors and trade in RMB; H shares face the Hong Kong market, including international investors, and trade in HKD. The same company therefore carries two prices, each set by its own market's supply and demand.
No cross-market conversion: A shares and H shares sit in separate registration, settlement, and trading systems; shares of the same class cannot be converted across markets, and the two-market price gap cannot be closed by moving shares.
2. Common listing sequences
Three orderings: Practice mainly includes: A shares listed first and H shares issued later; H shares listed first and A shares issued later; and same-day dual listing on both markets. The sequence affects the effective timing of H-share inclusion in Stock Connect Southbound: newly listed H shares are transferred in once the price stabilization period has ended and the corresponding A shares have been listed for ten trading days.
3. Distinction from dual primary listing and secondary listing
Dual primary listing: An A+H company holds primary listing status in both markets and must satisfy the listing rules and continuing obligations of both exchanges.
Secondary listing: A Secondary Listing refers to a company already primarily listed on another exchange that lists in Hong Kong as a second listing venue, carrying a regulatory arrangement distinct from the dual primary form of an A+H structure; companies listed only in another market, outside the A+H dual issuance structure, are not A+H issuers.
4. H shares and Stock Connect
Automatic inclusion: H shares of A+H issuers listed on SEHK fall directly within the scope of Southbound Stocks, free from HSCI constituent eligibility and market capitalization thresholds; where the corresponding A shares are placed under risk warning or enter a delisting arrangement, the H shares are excluded from Stock Connect Southbound.
5. The basis of the AH price gap
Two prices: Owing to differences in investor structure, liquidity, funding costs, and dividend tax arrangements, the A-share and H-share prices of the same company typically diverge, giving rise to the AH premium, measured in aggregate by the Hang Seng Stock Connect China AH Premium Index compiled by Hang Seng Indexes Company.
NewTimeSpace Observation: The A+H structure is the most direct sample for observing pricing differences between the two markets: one company, one set of fundamentals, two independently formed prices. Understanding this structure is the prerequisite groundwork for understanding the AH premium, the automatic Stock Connect inclusion of H shares, and cross-border capital flows.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TIME INTERCON (01729.HK): Completion Net Asset Value of 51% Acquisition at USD 68.4 Million
- SH ELECTRIC (02727.HK): RMB 1 Public Listing Transfer of 47.4% Equity Interest in Electric Gotion Completed, Transferee Being Nanjing Gotion Holding
- SHIMAO SERVICES (00873.HK): Appoints Liu Zhijian as Independent Non-Executive Director and Chairman of the Nomination Committee
- YANGTZEKIANG (00294.HK): Sells Entire Equity Interest in Subsidiary Zhuoyue Weaving (Guangzhou) for HKD 42 Million, Constituting a Discloseable Transaction
- CSPC PHARMA (01093.HK): SYS6010 Included in China's Breakthrough Therapy Designation List for Driver-Gene-Negative Non-Squamous NSCLC